Glucose Health, Inc. Appoints Veteran Financial Executive Edmund “Ned” Burke to Its Board of Directors
Glucose Health (OTC: GLUC) appointed veteran financial executive Edmund “Ned” Burke to its Board of Directors effective October 23, 2025. Burke brings 40+ years of financial services leadership from firms including Pioneer Funds and Fidelity, and most recently served as CEO of ALPS Distributors.
Key track record items: Burke grew ALPS AUM from $15 million to $225 million (~19.79% CAGR over ~15 years), negotiated ALPS’ sale to Lovell Minnick in 2005, and oversaw its later acquisition by DST Systems in 2011. He also serves on boards of Financial Investors Trust, Clough Funds, and Liberty All-Star Trust. Management notes Burke is one of Glucose Health’s largest shareholders and will support the company’s growth strategy.
Glucose Health (OTC: GLUC) ha nominato il veterano dirigente finanziario Edmund “Ned” Burke nel Consiglio di Amministrazione con effetto dal 23 ottobre 2025. Burke porta oltre 40 anni di leadership nei servizi finanziari da aziende tra cui Pioneer Funds e Fidelity, e recentemente è stato CEO di ALPS Distributors.
Principali elementi della sua track record: Burke ha aumentato gli AUM di ALPS da $15 milioni a $225 milioni (~19,79% CAGR in circa 15 anni), ha negoziato la vendita di ALPS a Lovell Minnick nel 2005 e ha supervisionato la successiva acquisizione da parte di DST Systems nel 2011. Siede anche nei consigli di Financial Investors Trust, Clough Funds e Liberty All-Star Trust. La direzione segnala che Burke è uno dei principali azionisti di Glucose Health e sosterrà la strategia di crescita dell’azienda.
Glucose Health (OTC: GLUC) designó al veterano ejecutivo financiero Edmund “Ned” Burke a su Junta Directiva con efecto a partir del 23 de octubre de 2025. Burke aporta más de 40 años de liderazgo en servicios financieros de firmas como Pioneer Funds y Fidelity, y recientemente fue CEO de ALPS Distributors.
Puntos clave de su trayectoria: Burke incrementó los AUM de ALPS de $15 millones a $225 millones (~19,79% CAGR durante ~15 años), negoció la venta de ALPS a Lovell Minnick en 2005 y supervisó su posterior adquisición por DST Systems en 2011. También integra consejos de Financial Investors Trust, Clough Funds y Liberty All-Star Trust. Según la dirección, Burke es uno de los mayores accionistas de Glucose Health y apoyará la estrategia de crecimiento de la empresa.
Glucose Health (OTC: GLUC)는 2025년 10월 23일부터 효력을 발휘하는 이사회 구성으로 Edmund “Ned” Burke를 선임했습니다. Burke는 Pioneer Funds와 Fidelity 등에서 40년이 넘는 금융 서비스 리더십을 보유하고 있으며 최근에는 ALPS Distributors의 CEO를 역임했습니다.
주요 경력 포인트: Burke는 ALPS의 운용 자산(AUM)을 $15백만에서 $225백만으로 성장시켰고 (~연평균 성장률 약 19.79% 약 15년간), 2005년 ALPS의 Lovell Minnick 매각을 협상했고 2011년 DST Systems의 후속 인수를 감독했습니다. 또한 Financial Investors Trust, Clough Funds, Liberty All-Star Trust 이사회에도 참여합니다. 경영진은 Burke가 Glucose Health의 최대 주주 중 한 명이며 회사의 성장 전략을 지지할 것이라고 밝힙니다.
Glucose Health (OTC: GLUC) a nommé Edmund “Ned” Burke, vétéran dirigeant financier, au conseil d’administration à compter du 23 octobre 2025. Burke apporte plus de 40 ans de leadership dans les services financiers de sociétés telles que Pioneer Funds et Fidelity, et a récemment été PDG d'ALPS Distributors.
Points clés de son parcours: Burke a fait passer l’Actifs Sous Gestion (AUM) d’ALPS de $15 millions à $225 millions (~19,79% CAGR sur environ 15 ans), a négocié la vente d’ALPS à Lovell Minnick en 2005 et a supervisé son acquisition ultérieure par DST Systems en 2011. Il siège également aux conseils de Financial Investors Trust, Clough Funds et Liberty All-Star Trust. La direction indique que Burke est l’un des plus grands actionnaires de Glucose Health et soutiendra la stratégie de croissance de l’entreprise.
Glucose Health (OTC: GLUC) hat den erfahrenen Finanzmanager Edmund “Ned” Burke mit Wirkung zum 23. Oktober 2025 in den Vorstand berufen. Burke bringt über 40 Jahre Führungserfahrung im Finanzdienstleistungsbereich von Unternehmen wie Pioneer Funds und Fidelity mit und war zuletzt CEO von ALPS Distributors.
Wichtige Track-Record-Punkte: Burke hat das von ALPS verwaltete Vermögen (AUM) von $15 Millionen auf $225 Millionen gesteigert (~19,79% CAGR über ca. 15 Jahre), den Verkauf von ALPS an Lovell Minnick im Jahr 2005 verhandelt und seine spätere Übernahme durch DST Systems im Jahr 2011 beaufsichtigt. Er sitzt auch in den Aufsichtsräten von Financial Investors Trust, Clough Funds und Liberty All-Star Trust. Die Geschäftsführung merkt an, dass Burke einer der größten Aktionäre von Glucose Health ist und die Wachstumsstrategie des Unternehmens unterstützen wird.
Glucose Health (OTC: GLUC) عيّنت Edmund “Ned” Burke كعضو مجلس إدارة اعتباراً من 23 أكتوبر 2025. يجلب Burke أكثر من 40 عاماً من القيادة في الخدمات المالية من شركات مثل Pioneer Funds وFidelity، ولديه آخر منصب كـCEO لـ ALPS Distributors.
عناصر رئيسية للسجل: رفع Burke الأصول الخاضعة للإدارة في ALPS من $15 مليوناً إلى $225 مليون (~معدل نمو سنوي مركب ≈ 19.79% على مدار نحو 15 عاماً)، وتفاوضه على بيع ALPS إلى Lovell Minnick في 2005، والإشراف على استحواذها في وقت لاحق من قبل DST Systems في 2011. كما يخدم في مجالس إدارة Financial Investors Trust وClough Funds وLiberty All-Star Trust. تقول الإدارة إن Burke واحد من أكبر المساهمين في Glucose Health وسوف يدعم استراتيجية نمو الشركة.
Glucose Health (OTC: GLUC) 已任命资深金融高管 Edmund “Ned” Burke 于2025年10月23日生效的董事会成员。Burke在金融服务领域拥有40多年的领导经验，曾任职于Pioneer Funds和Fidelity等公司，最近担任ALPS Distributors的首席执行官。
关键成就要点：Burke将ALPS的资产管理规模（AUM）从$15百万美元增至$225百万美元（约19.79% CAGR，约15年），在2005年促成ALPS向Lovell Minnick的出售，并监督其于2011年被DST Systems收购。他还在Financial Investors Trust、Clough Funds和Liberty All-Star Trust担任董事会成员。管理层表示，Burke是Glucose Health的最大股东之一，将支持公司的增长策略。
- ALPS AUM growth from $15M to $225M
- 19.79% CAGR at ALPS over ~15 years
- Burke is a company large shareholder aligning interests
- None.
BENTONVILLE, Ark., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Glucose Health, Inc. (OTC: GLUC) is pleased to announce the appointment of Edmund (Ned) Burke, a highly accomplished financial services executive, to its Board of Directors. With more than four decades of leadership experience at prominent investment firms including Pioneer Funds and Fidelity Investments, Mr. Burke brings exceptional financial acumen and strategic insight to the company’s leadership team.
Mr. Burke most recently served as Chief Executive Officer of ALPS Distributors, Inc., where he played a pivotal role in the successful distribution of closed-end funds and exchange-traded funds (ETFs). Under his direction, ALPS expanded its services to include critical back-office accounting and transfer services for many of the nation’s top money management firms. During his tenure, Mr. Burke established and managed key relationships with notable organizations such as Select Sector SPDR Exchange Traded Funds, GE Investment Management, and Clough closed-end funds.
His outstanding contributions to the financial services industry were recognized in 2016 when he received the NOVA Award from the National Investment Company Service Association, honoring his leadership and innovation in the securities sector.
As CEO, Mr. Burke oversaw impressive growth at ALPS, expanding the firm’s Assets Under Management (AUM) from
Mr. Burke’s extensive experience in building and scaling financial organizations will be invaluable as Glucose Health, Inc., continues to expand operations and enhance shareholder value. In addition to his new role at Glucose Health, Mr. Burke serves on the boards of several prominent money management firms, including Financial Investors Trust, Clough Funds, and Liberty All-Star Trust.
Commenting on the appointment, Mark Schaftlein, CEO of Glucose Health, stated:
“Ned is an outstanding addition to our Board of Directors. His deep industry expertise and proven success in building high-performing organizations will be instrumental as we continue to advance Glucose Health’s growth strategy. As one of our largest shareholders, Ned’s interests are perfectly aligned with those of our broader shareholder base, and I look forward to working closely with him to achieve our long-term objectives.”
Mr. Burke earned a Bachelor of Arts degree in Economics from the University of New Hampshire.
Contact: Investor Relations info@glucosehealthinc.com www.glucodown.com www.fiberup.com OTC: GLUC
FAQ
Who is Edmund “Ned” Burke and why did Glucose Health (GLUC) add him to the board on October 23, 2025?
How did Ned Burke grow ALPS AUM before joining Glucose Health’s board?
Does Ned Burke hold shares in Glucose Health (GLUC) and what does that mean for investors?
What previous exits or transactions has Ned Burke led that are relevant to GLUC investors?
Will Ned Burke’s appointment to Glucose Health’s board change company strategy or guidance immediately?
How can investors contact Glucose Health investor relations about the board appointment (GLUC)?
